Verma R, Jaiswal T N
Division of Standardisation, Indian Veterinary Research Institute, Izatnagar, India.
Vaccine. 1998 Jul;16(11-12):1184-92. doi: 10.1016/s0264-410x(98)80118-7.
Haemorrhagic septicaemia (HS), an economically important disease of cattle and buffaloes, is caused by Pasteurella multocida (6:B). Vaccination against this disease is widely practised. Plain broth bacterins, or alum precipitated and aluminium hydroxide gel vaccines are administered twice a year since these vaccines offer an immunity of 4-6 months. Many countries use oil adjuvant vaccine (OAV), which gives both a higher degree and a longer duration of immunity up to 1 year. A double emulsion and multiple emulsion vaccine consisting of a thin viscosity have also been experimentally developed that gave an immunity parallel to OAV. Recently, a live vaccine developed from a fallow deer strain (B:3,4) has been used in Myanmar that offers an immunity for more than a year but is not free from constraints. The present review provides information on HS vaccines developed from time to time using whole bacteria or their components. The kinetics and isotype of antibody and cell-mediated immune responses have also been poorly understood so far, and hence information on their role in protection against HS is reviewed.
出血性败血症(HS)是牛和水牛的一种具有经济重要性的疾病,由多杀性巴氏杆菌(6:B)引起。针对这种疾病的疫苗接种广泛开展。普通肉汤菌苗、明矾沉淀疫苗和氢氧化铝凝胶疫苗每年接种两次,因为这些疫苗提供4至6个月的免疫力。许多国家使用油佐剂疫苗(OAV),其免疫程度更高且持续时间长达1年。还通过实验开发了一种由低粘度组成的双重乳液和多重乳液疫苗,其产生的免疫力与OAV相当。最近,一种由梅花鹿菌株(B:3,4)开发的活疫苗已在缅甸使用,该疫苗提供超过一年的免疫力,但并非没有限制。本综述提供了有关不时使用全细菌或其成分开发的HS疫苗的信息。迄今为止,人们对抗体和细胞介导免疫反应的动力学和同种型也了解甚少,因此对它们在预防HS中的作用的信息进行了综述。